Filing Details

Accession Number:
0000014272-21-000202
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-16 17:51:52
Reporting Period:
2021-08-12
Accepted Time:
2021-08-16 17:51:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1451604 V David Elkins 430 E. 29Th Street
14Th Floor
New York NY 10016
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Disposition 2021-08-12 40,000 $66.88 69,699 No 4 S Direct
Common Stock, $0.10 Par Value Acquisiton 2021-08-12 6,180 $48.49 75,879 No 4 M Direct
Common Stock, $0.10 Par Value Acquisiton 2021-08-12 4,129 $48.49 80,008 No 4 M Direct
Common Stock, $0.10 Par Value Acquisiton 2021-08-12 59,691 $48.49 139,699 No 4 M Direct
Common Stock, $0.10 Par Value Disposition 2021-08-12 59,691 $67.00 80,008 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.10 Par Value Option (right to buy) Disposition 2021-08-12 6,180 $0.00 6,180 $48.49
Common Stock, $0.10 Par Value Option (right to buy) Disposition 2021-08-12 4,129 $0.00 4,129 $48.49
Common Stock, $0.10 Par Value Option (right to buy) Disposition 2021-08-12 59,691 $0.00 59,691 $48.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,063 2028-08-01 No 4 M Direct
121,214 2028-08-01 No 4 M Direct
0 2028-08-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.10 Par Value 198 Indirect BMS Savings and Investment Program
Footnotes
  1. Shares acquired from options exercised in a net exercise and hold transaction with broker.
  2. 59,691 shares were sold in an exercise and sell transaction, covering the exercise price and taxes in accordance with the broker's procedures. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $66.865 to $67.09, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  3. Based on a plan statement as of the end of the most recent fiscal quarter.
  4. All of the shares are currently exercisable.